Cyprotex PLC — Form D
Cyprotex PLC of MANCHESTER, X0, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-17. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-08-17
- Form: D
- Accession: 0001499299-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.7M
- Amount sold: $2.7M
- Investors: 2
- Date of first sale: 2010-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-146539
Issuer
- Name: Cyprotex PLC
- CIK: 0001499299
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Address: 100 BARBIROLLI SQUARE, MANCHESTER, X0, M2 3AB
- Phone: 44 (0) 1625 505100
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Anthony David Baxter | Director | Manchester, X0 |
| John Kevin Dootson | Director | Manchester, X0 |
| Ralph Stephen Harris | Director | Manchester, X0 |
| Anthony David Baxter | Executive Officer | Manchester, X0 |
| John Kevin Dootson | Executive Officer | Manchester, X0 |
More